Lissoni P, Malugani F, Brivio F, Piazza A, Vintimilla C, Giani L, Tancini G.
Clinical Trial 2003; 24(3-4): 259-262 PubMed PMID: 14523367 Keywords: 5-Methoxytryptamine:administration & dosage, Aged, Aged, 80 and over, Antineoplastic Agents:therapeutic use, Antioxidants:administration & dosage, Disease Progression, Female, Humans, Hydroxyindoleacetic Acid:administration & dosage, Indoles:administratio. CitationOBJECTIVES: It is known since many years that the pineal gland plays an anticancer role, and melatonin (MLT), the most investigated pineal.....
Lissoni P, Malugani F, Brivio F, Piazza A, Vintimilla C, Giani L, Tancini G. Total pineal endocrine substitution therapy (TPEST) as a new neuroendocrine palliative treatment of untreatable metastatic solid tumor patients: a phase II study. Neuro Endocrinol Lett. 2003 Aug; 24(3-4): 259-262
Lissoni P, Malugani F, Bukovec R, Bordin V, Perego M, Mengo S, Ardizzoia A, Tancini G.
Clinical Trial 2003; 24(1-2): 83-85 PubMed PMID: 12743539 Keywords: 5-Methoxytryptamine:metabolism, Aged, Anemia:chemically induced, Antineoplastic Agents:adverse effects, Carcinoma, Non-Small-Cell Lung:complications, Cisplatin:adverse effects, Erythropoiesis:drug effects, Female, Hemoglobins:metabolism, Humans, Lung Neop. CitationOBJECTIVE: It has been demonstrated that the hematopoiesis is under a neuroendocrine control, namely mediated by the pineal gland. The pin.....
Lissoni P, Malugani F, Bukovec R, Bordin V, Perego M, Mengo S, Ardizzoia A, Tancini G. Reduction of cisplatin-induced anemia by the pineal indole 5-methoxytryptamine in metastatic lung cancer patients. Neuro Endocrinol Lett. 2003 Apr; 24(1-2): 83-85
Lissoni P, Malugani F, Manganini V, Ardizzoia A, Gardani G, Bartolacelli E, Messina G, Tancini G.
Clinical Trial 2003; 24(1-2): 50-53 PubMed PMID: 12743532 Keywords: Adult, Apomorphine:pharmacology, Disease Progression, Human Growth Hormone:blood, Humans, Hydrocortisone:blood, Male, Neoplasm Metastasis, Neoplasms:physiopathology, Neurosecretory Systems:drug effects, Prolactin:blood,. CitationOBJECTIVES: The clinical approach of the Psychooncology is generally limited to the investigation of the only psychological status of canc.....
Lissoni P, Malugani F, Manganini V, Ardizzoia A, Gardani G, Bartolacelli E, Messina G, Tancini G. Psychooncology and cancer progression-related alterations of pleasure-associated neurochemical system: Abnormal neuroendocrine response to apomorphine in advanced cancer patients. Neuro Endocrinol Lett. 2003 Apr; 24(1-2): 50-53
Lissoni P, Malugani F, Malysheva O, Kozlov V, Laudon M, Conti A, Maestroni G.
Clinical Trial 2002; 23(4): 341-344 PubMed PMID: 12195238 Keywords: Adjuvants, Immunologic:administration & dosage, Aged, Antineoplastic Agents:administration & dosage, Carcinoma, Neuroendocrine:drug therapy, Carcinoma, Renal Cell:drug therapy, Digestive System Neoplasms:drug therapy, Female, Humans, Injections, Subcutane. CitationOBJECTIVES: The preliminary applications of the psychoneuroimmunological knowledges to the treatment of human diseases have confirmed the .....
Lissoni P, Malugani F, Malysheva O, Kozlov V, Laudon M, Conti A, Maestroni G. Neuroimmunotherapy of untreatable metastatic solid tumors with subcutaneous low-dose interleukin-2, melatonin and naltrexone: modulation of interleukin-2-induced antitumor immunity by blocking the opioid system. Neuro Endocrinol Lett. 2002 Aug; 23(4): 341-344
Lissoni P, Malugani F, Bordin V, Conti A, Maestroni G, Tancini G.
Clinical Trial 2002; 23(3): 255-258 PubMed PMID: 12080288 Keywords: Aged, Antineoplastic Agents:administration & dosage, Carcinoma, Renal Cell:drug therapy, Drug Therapy, Combination, Female, Humans, Injections, Subcutaneous, Interleukin-2:administration & dosage, Kidney Neoplasms:drug therapy, Lymphocyte Count, Male, Mid. CitationOBJECTIVES: Recent advances in knowledge of Psychoneuroimmunology have shown that several neuroactive substances, including neurohormones .....
Lissoni P, Malugani F, Bordin V, Conti A, Maestroni G, Tancini G. A new neuroimmunotherapeutic strategy of subcutaneous low-dose interleukin-2 plus the long-acting opioid antagonist naltrexone in metastatic cancer patients progressing on interleukin-2 alone. Neuro Endocrinol Lett. 2002 Jun; 23(3): 255-258
Lissoni P, Malugani F, Casu M, Bukovec R, Egardi R, Bordin V, Fumagalli E, Mengo S, Gardani G.
Clinical Trial 2002; 23(1): 61-63 PubMed PMID: 11880864 Keywords: Aged, Androgen Antagonists:therapeutic use, Anilides:therapeutic use, Humans, Levodopa, Male, Middle Aged, Nitriles, Prolactin:blood, Prostatic Neoplasms:blood, Tosyl Compounds,. CitationOBJECTIVES: The secretion of prolactin (PRL), which is a growth factor for prostate cancer cell proliferation, has been proven to present .....
Lissoni P, Malugani F, Casu M, Bukovec R, Egardi R, Bordin V, Fumagalli E, Mengo S, Gardani G. Effect of bicalutamide therapy on prolactin response to L-dopa in metastatic prostate cancer patients. Neuro Endocrinol Lett. 2002 Feb; 23(1): 61-63